Top Back to top

2nd EBMT-China Scientific Forum Hybrid

Acute Myeloid Leukaemia (AML)
Event type:
Educational Meeting
Tianjin and Online
Presenters / Organizers :
​Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, ​EBMT Foundation Shanghai Office

2nd EBMT-China Meeting Header

Dear Distinguished Experts and Professors:

It is our great honor to invite you to attend ‘’the Second EBMT-China Scientific Forum’’ jointly organised by the Institute of Haematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, and the EBMT Foundation Shanghai Office.

This in-person and online event aims to provide a platform for academic exchange and mutual learning by pooling insights and novel ideas from world-class experts and scholars in the fields of hematology and blood and marrow transplantation from China and Europe. The forum will serve to enhance innovation and communication on new treatments and therapies, as well as promote discussions of cutting-edge clinical research results in the aforementioned fields between China and Europe, with the pursuit of initiating clinical-demand-oriented multi-center research cooperation. Specifically, this forum, themed ''Acute Leukaemia'', highlights discussions concerning topics such as Chemotherapy in AML and the latest developments in Emerging Drugs, MRD Guides AML Treatment Choices, Autologous, Allogeneic Haematopoietic Stem Cell Transplantation for AML and more. Participants will have the opportunity to draw on novel research outcomes and updated development results in the fields.

The forum is scheduled for 18 November 2022 and will be held onsite in Tianjin and online. We are looking forward to your esteemed presence, either in-person or virtually, at this academic event!


们十分荣幸地邀请您参加由中国医学科学院血液病医院(中国医学科学院血液学研 究所)和欧洲血液和骨塩移植协会(荷兰)基金会上海代表处共同主办的第二届 EBMT-中国科学论坛

本次论坛采用线上线下相结合的方式,旨在为国内外血液和骨髓移植领域的顶级专 家学者们提供交流互鉴的平台,促进中欧在血液和骨認移植领域新药物和新疗法的创新 与交流、前沿临床研究成果的分享与

讨,以临床需求为导向,启动多中心研究合作。本届论坛主题为急性白血病,将围绕AML疗及新型药物进展、MRDAML 治疗选择、AML的自体和异基因造血干细胞移植等课题进行深入探讨和洞见分享。


There is no registration and the forum is free to attend virtually through the following link:

Date: 18th November 2022

Time: Friday morning from 8:00-12:30 CET 

Forum Link:

Please refer to the preliminary programme linked above.

Due to the current travel limitations to China, only Chinese locals in fields of haematology and blood and marrow transplantation will be able to attend this forum onsite at Tianjin, China.

Attendees located outside of China and virtual attendees will be able to attend this forum online through a link provided to this webpage a couple days before the start of the meeting.